These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25744802)

  • 1. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
    Larsdotter S; Nostell K; von Euler H
    Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
    Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
    J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
    von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
    J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
    Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of a commercially available thymidine kinase 1 assay for diagnosis of lymphoma in 42 hospitalized horses (2017-2020).
    Moore C; Stefanovski D; Luethy D
    J Vet Intern Med; 2021 Sep; 35(5):2495-2499. PubMed ID: 34359096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.
    Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H
    BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
    Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
    Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].
    Aul C; Germing U; Gattermann N; Söhngen D; Heyll A
    Dtsch Med Wochenschr; 1996 Sep; 121(37):1113-8. PubMed ID: 8925725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.
    Selting KA; Ringold R; Husbands B; Pithua PO
    J Vet Intern Med; 2016 Jul; 30(4):1159-66. PubMed ID: 27214230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
    Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
    Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
    He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
    Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
    Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
    PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial.
    Brown RD; Joshua DE; Nelson M; Gibson J; Dunn J; MacLennan IC
    Br J Haematol; 1993 Jun; 84(2):238-41. PubMed ID: 8398824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine kinase assay in canine lymphoma.
    Elliott JW; Cripps P; Blackwood L
    Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
    Madewell BR
    J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thymidine kinase in diagnosis and follow-up of the small cell carcinoma of the lung.
    Abbasciano V; Graziano L; Arcudi D; Felisatti G; Cavallini AR; Reali MG; Calia N; Campi S; Guglielmini C
    Med Oncol Tumor Pharmacother; 1991; 8(1):29-34. PubMed ID: 1645826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
    Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
    Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma matrix metalloproteinase-9 activity in cats with lymphoma.
    Tamamoto T; Ohno K; Takahashi M; Fukushima K; Kanemoto H; Fujino Y; Tsujimoto H
    Vet Comp Oncol; 2017 Mar; 15(1):1-5. PubMed ID: 24899544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions.
    Perkins GA; Nydam DV; Flaminio MJ; Ainsworth DM
    J Vet Intern Med; 2003; 17(3):337-42. PubMed ID: 12774976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.